Status:
UNKNOWN
Cognitive Impairment , Neuroimaging and Inflammatory Markers in Patients With Subcortical Ischemic Vascular Disease
Lead Sponsor:
Hebei General Hospital
Conditions:
Other Generalized Ischemic Cerebrovascular Disease
Eligibility:
All Genders
50+ years
Brief Summary
SIVD is characterised by extensive cerebral white matter lesions (WML) and lacunar infarcts in deep grey and white matter structures. The relationship between SIVD and cognition is unclear, in part be...
Detailed Description
1. Contributions of white matter lesions to cognitive impairment in patients with subcortical ischemic vascular disease 1. Extensive neuropsychological tests including MMSE and covering 5 cognitiv...
Eligibility Criteria
Inclusion
- Clinical diagnosis of subcortical ischemic vascular disease
- Must exist cognitive impairment
Exclusion
- serious dementia could not speak , listen and white
- other diseases which might cause dementia
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01418885
Start Date
September 1 2010
End Date
December 1 2011
Last Update
August 17 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yanhongdong
Shijiazhuang, Hebei, China, 050051